Ewing sarcoma in pregnancy: A rare case report

Author: Edzel M. Magtoto ¹ ; Maximino Bello III ² ; Ruzabeth K. Cuya ³ ; Joanna Pauline C. Ursua ⁴
Author Information

1. Resident, Internal Medicine Department, Delos Santos Medical Center, Quezon City
2. Section of Oncology, Delos Santos Medical Center, Quezon City
3. Department of Obstetrics and Gynecology, Delos Santos Medical Center, Quezon City
4. Section of Perinatology, Delos Santos Medical Center, Quezon City
Publication Type:Case Reports
Keywords: Erwing Sarcoma; Doxorubucin; Pregrancy; Neoadjuvant
MeSH: Neoplasms; Drug Therapy
From: Journal of the Philippine Medical Association 2023;102(1):103-110
CountryPhilippines
Language:English
Abstract: This is a case of 34-year-old female Gravida 1 Para 1 37 weeks age of gestation and has been diagnosed as a case of Extraskeletal Ewing Sarcoma, Right Axillary Mass Grade 3 during the first trimester. Patient had received 4 cycles of Doxorubucin as part of the "Bridging Therapy" and Chemotherapeutic regimen. Chemotherapy has been pursued to this patient, initiated on the 21st week of gestation with hopes to decrease the size of the mass and alleviate the pain during the course of pregnancy. The ethical and therapeutic concerns for both the patient and the physician remains to be a challenge up to this course. A multidisciplinary approach was instigated to weigh risks versus benefit for the expecting mother and the unborn child.
Full text:jpma 11.pdf